MicroRNAs (miRNAs) are small RNAs comprised of 20–25 nucleotides that regulates gene expression by inducing translational repression or degradation of target mRNA. The importance of miRNAs as a mediator of disease pathogenesis and therapeutic targets is rapidly emerging in neuroscience, as well as oncology, immunology, and cardiovascular diseases. In Parkinson’s disease and related disorders, multiple studies have identified the implications of specific miRNAs and the polymorphisms of miRNA target genes during the disease pathogenesis. With a focus on Parkinson’s disease, spinocerebellar ataxia, hereditary spastic paraplegia, and Huntington’s disease, this review summarizes and interprets the observations, and proposes future research topics in this field.

Citations

Citations to this article as recorded by  

• Rapid colorimetric analysis of multiple microRNAs using encoded hydrogel microparticles
  Ju Yeon Kim, Seok Joon Mun, Yoon Ho Roh, Ki Wan Bong
  The Analyst.2021; 146(18): 5508.     CrossRef
• Depressive symptoms are associated with a functional polymorphism in a miR-433 binding site in the FGF20 gene
  Karen M. Jiménez, Angela J. Pereira-Morales, Ana Adan, Sandra Lopez-Leon, Diego A. Forero
  Molecular Brain.2018;[Epub]     CrossRef
• MiR-144 promotes β-amyloid accumulation-induced cognitive impairments by targeting ADAM10 following traumatic brain injury
  Liqian Sun, Manman Zhao, Jingbo Zhang, Aihua Liu, Wenjun Ji, Youxiang Li, Xinjian Yang, Zhongxue Wu
  Oncotarget.2017; 8(35): 59181.     CrossRef
• Systematic literature review on Parkinson's disease and Childhood Leukaemia and mode of actions for pesticides
  Judy Choi, Alexandra Polcher, Anke Joas
  EFSA Supporting Publications.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy
  Seojin Lee, Ivan Martinez-Valbuena, Anthony E. Lang, Gabor G. Kovacs
  Neurobiology of Disease.2024; 197: 106535.     CrossRef
• The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases
  Seojin Lee, Gabor G. Kovacs
  International Journal of Molecular Sciences.2024; 25(8): 4269.     CrossRef
• Comparison of the second consensus statement with the movement disorder society criteria for multiple system atrophy: A single-center analysis
  Yunchuang Sun, Wei Sun, Luhua Wei, Fan Li, Yanyan Jiang, Fei Zhai, Mingyue Luan, Jing Chen, Zhaoxia Wang
  Parkinsonism & Related Disorders.2023; 106: 105242.     CrossRef
• Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy
  Alexander Rau, Nils Schröter, Michel Rijntjes, Fabian Bamberg, Wolfgang H. Jost, Maxim Zaitsev, Cornelius Weiller, Stephan Rau, Horst Urbach, Marco Reisert, Maximilian F. Russe
  European Radiology.2023; 33(10): 7160.     CrossRef
• Multi-parametric radiomics of conventional T1 weighted and susceptibility-weighted imaging for differential diagnosis of idiopathic Parkinson’s disease and multiple system atrophy
  Shuting Bu, Huize Pang, Xiaolu Li, Mengwan Zhao, Juzhou Wang, Yu Liu, Hongmei Yu
  BMC Medical Imaging.2023;[Epub]     CrossRef
• Diagnostic performance of T2* gradient echo, susceptibility-weighted imaging, and quantitative susceptibility mapping for patients with multiple system atrophy–parkinsonian type: a systematic review and meta-analysis
  Su Jin Lim, Chong Hyun Suh, Woo Hyun Shim, Sang Joon Kim
  European Radiology.2022; 32(1): 308.     CrossRef
• An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders
  Nicola Tambasco, Pasquale Nigro, Andrea Chiappiniello, Federico Paolini Paoletti, Sara Scialpi, Simone Simoni, Pietro Chiarini, Lucilla Parnetti, Barbara Picconi
  Behavioural Neurology.2022; 2022: 1.     CrossRef
• Automated Differentiation of Atypical Parkinsonian Syndromes Using Brain Iron Patterns in Susceptibility Weighted Imaging
  Yun Soo Kim, Jae-Hyeok Lee, Jin Kyu Gahm
  Diagnostics.2022; 12(3): 637.     CrossRef
• The “Black Straight-Line Sign” in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy
  Yiming Zheng, Xiwen Wang, Huajian Zhao, Yanyan Jiang, Ying Zhu, Jing Chen, Wei Sun, Zhaoxia Wang, Yunchuang Sun
  Frontiers in Neurology.2022;[Epub]     CrossRef
• Role of zinc transporter ZIP12 in susceptibility‐weighted brain magnetic resonance imaging (MRI) phenotypes and mitochondrial function
  Morgan D. Strong, Matthew D. Hart, Tony Z. Tang, Babajide A. Ojo, Lei Wu, Mariah R. Nacke, Workneh T. Agidew, Hong J. Hwang, Peter R. Hoyt, Ahmed Bettaieb, Stephen L. Clarke, Brenda J. Smith, Barbara J. Stoecker, Edralin A. Lucas, Dingbo Lin, Winyoo Chowa
  The FASEB Journal.2020; 34(9): 10702.     CrossRef
• Current Management and Emerging Therapies in Multiple System Atrophy
  Matthew R. Burns, Nikolaus R. McFarland
  Neurotherapeutics.2020; 17(4): 1582.     CrossRef
• Morphology and signal changes of the lentiform nucleus based on susceptibility weighted imaging in parkinsonism-predominant multiple system atrophy
  Qingguo Ren, Xiangshui Meng, Bin Zhang, Jianyuan Zhang, Xinyan Shuai, Xiaomin Nan, Cuiping Zhao
  Parkinsonism & Related Disorders.2020; 81: 194.     CrossRef
• The Utility of Susceptibility-Weighted Imaging in the Diagnosis of Multiple System Atrophy, Cerebellar Type
  Halil Onder
  Journal of Medical Sciences.2020; 42(1): 53.     CrossRef
• Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy
  Florian Krismer, Klaus Seppi, Gregor K. Wenning, Spyridon Papapetropoulos, Victor Abler, Georg Goebel, Michael Schocke, Werner Poewe
  Parkinsonism & Related Disorders.2019; 58: 23.     CrossRef
• Brain Iron Accumulation in Atypical Parkinsonian Syndromes: in vivo MRI Evidences for Distinctive Patterns
  Jae-Hyeok Lee, Myung-Sik Lee
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Quantitative Validation of a Visual Rating Scale for Defining High-Iron Putamen in Patients With Multiple System Atrophy
  Myung Jun Lee, Tae-Hyung Kim, Seung Joo Kim, Baik-Kyun Kim, Chi-Woong Mun, Jae-Hyeok Lee
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase–Associated Neurodegeneration
  J.-H. Lee, A. Gregory, P. Hogarth, C. Rogers, S.J. Hayflick
  American Journal of Neuroradiology.2018; 39(3): 583.     CrossRef
• The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
  Christine Kaindlstorfer, Kurt A. Jellinger, Sabine Eschlböck, Nadia Stefanova, Günter Weiss, Gregor K. Wenning
  Journal of Alzheimer's Disease.2018; 61(4): 1253.     CrossRef
• Using ‘swallow-tail’ sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson’s disease: A susceptibility-weighted imaging study
  Na Wang, HuaGuang Yang, ChengBo Li, GuoGuang Fan, XiaoGuang Luo
  European Radiology.2017; 27(8): 3174.     CrossRef
• Magnetic resonance imaging for the diagnosis of Parkinson’s disease
  Beatrice Heim, Florian Krismer, Roberto De Marzi, Klaus Seppi
  Journal of Neural Transmission.2017; 124(8): 915.     CrossRef
• Utility of susceptibility-weighted imaging in Parkinson’s disease and atypical Parkinsonian disorders
  Zhibin Wang, Xiao-Guang Luo, Chao Gao
  Translational Neurodegeneration.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Outcomes of stereotactic thalamotomy in patients of essential tremor: A systematic review
  Sagun Ghimire, Bibechan Thapa, Durga Neupane, Pashupati Pokharel
  Journal of Clinical Neuroscience.2024; 126: 38.     CrossRef
• Displaced center of pressure on the treated side in individuals with essential tremor after radiofrequency ablation: a longitudinal case–control study
  Atsuya Sato, Takaomi Taira, Kazuya Kitada, Toshiki Ando, Toyohiro Hamaguchi, Michiko Konno, Yoshinori Kitabatake, Toshiyuki Ishioka
  Frontiers in Neurology.2023;[Epub]     CrossRef
• Commentary on: A Network Approach to Understanding the Effects of Focused Ultrasound for Essential Tremor: Insights into Pathophysiology, Treatment, and Imaging Biomarkers
  Prashin Unadkat, David Eidelberg
  Neurotherapeutics.2022; 19(6): 1883.     CrossRef
• Deep Brain Stimulation for Tremor: Update on Long-Term Outcomes, Target Considerations and Future Directions
  Naomi I. Kremer, Rik W. J. Pauwels, Nicolò G. Pozzi, Florian Lange, Jonas Roothans, Jens Volkmann, Martin M. Reich
  Journal of Clinical Medicine.2021; 10(16): 3468.     CrossRef
• Clinical improvement associated with targeted interruption of the cerebellothalamic tract following MR-guided focused ultrasound for essential tremor
  J. Levi Chazen, Harini Sarva, Philip E. Stieg, Robert J. Min, Douglas J. Ballon, Kane O. Pryor, Paul M. Riegelhaupt, Michael G. Kaplitt
  Journal of Neurosurgery.2018; 129(2): 315.     CrossRef
• Innovations in Functional Neurosurgery and Anesthetic Implications
  Lauren K. Dunn, Marcel E. Durieux, W. Jeffrey Elias, Edward C. Nemergut, Bhiken I. Naik
  Journal of Neurosurgical Anesthesiology.2018; 30(1): 18.     CrossRef
• Surgical treatments for essential tremor
  Rodger J. Elble, Ludy Shih, Jeffrey W. Cozzens
  Expert Review of Neurotherapeutics.2018; 18(4): 303.     CrossRef
• The Current Status of Deep Brain Stimulation for the Treatment of Parkinson Disease in the Republic of Korea
  Jung-Il Lee
  Journal of Movement Disorders.2015; 8(3): 115.     CrossRef

Citations

Citations to this article as recorded by  

• Long‐term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10‐year follow‐up study
  Hong Xu, Annegret Habich, Daniel Ferreira, Londos Elisabet, Eric Westman, Maria Eriksdotter
  Alzheimer's & Dementia.2024;[Epub]     CrossRef
• Deep Learning Segmentation of the Nucleus Basalis of Meynert on 3T MRI
  D.J. Doss, G.W. Johnson, S. Narasimhan, J.S. Shless, J.W. Jiang, H.F.J. González, D.L. Paulo, A. Lucas, K.A. Davis, C. Chang, V.L. Morgan, C. Constantinidis, B.M. Dawant, D.J. Englot
  American Journal of Neuroradiology.2023; 44(9): 1020.     CrossRef
• Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRI
  Eya Khadhraoui, Sebastian Johannes Müller, Niels Hansen, Christian Heiner Riedel, Philip Langer, Charles Timäeus, Jens Wiltfang, Caroline Bouter, Claudia Lange, Marielle Ernst
  BMC Neurology.2022;[Epub]     CrossRef
• Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer’s disease
  Julia Schumacher, Nicola J Ray, Calum A Hamilton, Paul C Donaghy, Michael Firbank, Gemma Roberts, Louise Allan, Rory Durcan, Nicola Barnett, John T O’Brien, John-Paul Taylor, Alan J Thomas
  Brain.2022; 145(5): 1773.     CrossRef
• Metric magnetic resonance imaging analysis reveals pronounced substantia-innominata atrophy in dementia with Lewy bodies with a psychiatric onset
  Niels Hansen, Sebastian Johannes Müller, Eya Khadhraoui, Christian Heiner Riedel, Philip Langer, Jens Wiltfang, Charles-Arnold Timäus, Caroline Bouter, Marielle Ernst, Claudia Lange
  Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
• In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies
  Julia Schumacher, John-Paul Taylor, Calum A. Hamilton, Michael Firbank, Ruth A. Cromarty, Paul C. Donaghy, Gemma Roberts, Louise Allan, Jim Lloyd, Rory Durcan, Nicola Barnett, John T. O'Brien, Alan J. Thomas
  NeuroImage: Clinical.2021; 30: 102604.     CrossRef
• EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer’s disease
  Julia Schumacher, Alan J. Thomas, Luis R. Peraza, Michael Firbank, Ruth Cromarty, Calum A. Hamilton, Paul C. Donaghy, John T. O’Brien, John-Paul Taylor
  Alzheimer's Research & Therapy.2020;[Epub]     CrossRef
• Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies
  Gabriel Santpere, Paula Garcia‐Esparcia, Pol Andres‐Benito, Belen Lorente‐Galdos, Arcadi Navarro, Isidro Ferrer
  Brain Pathology.2018; 28(3): 315.     CrossRef
• Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations
  Deepak Kumbhare, Viktoras Palys, Jamie Toms, Chathurika S. Wickramasinghe, Kasun Amarasinghe, Milos Manic, Evan Hughes, Kathryn L. Holloway
  Frontiers in Neuroscience.2018;[Epub]     CrossRef
• Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
  Paula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, María Francisca García-Garrido, Anusha Konetti, Franc Llorens, Saima Zafar, Margarita Carmona, José Antonio del Rio, Inga Zerr, Ellen Gelpi, Isidro Ferrer
  Frontiers in Neurology.2017;[Epub]     CrossRef
• Meynert’s Nucleus Complex White Matter Abnormalities in Autism Spectrum Disorders: An MRI Study
  Matteo Pardini, Francesco G. Garaci, Laszlo Zaborszky, Filadelfo Coniglione, Gianluca Serafini, Martina Siracusano, Francesca Benassi, Leonardo Emberti Gialloreti
  Journal of Intellectual Disability - Diagnosis and Treatment.2017; 4(4): 185.     CrossRef
• Biomarkers for dementia and mild cognitive impairment in Parkinson's disease
  Manuel Delgado‐Alvarado, Belén Gago, Irene Navalpotro‐Gomez, Haritz Jiménez‐Urbieta, María C. Rodriguez‐Oroz
  Movement Disorders.2016; 31(6): 861.     CrossRef
• Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease
  Alan King Lun Liu, Raymond Chuen-Chung Chang, Ronald K. B. Pearce, Steve M. Gentleman
  Acta Neuropathologica.2015; 129(4): 527.     CrossRef

Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed NMS after abrupt reduction of antiparkinsonian medication and concurrent infection. It should be kept in mind that the prevention of infectious illness, which is common complication in parkinson-plus syndrome, is important, and dose reduction or withdrawal of anti-parkinsonian medications should be carefully performed even in the patients with CBD who are expected to be unresponsive to levodopa treatment.

Citations

Citations to this article as recorded by  

• Diagnosis and Management of Progressive Corticobasal Syndrome
  Claire Delpirou Nouh, Kyan Younes
  Current Treatment Options in Neurology.2024; 26(7): 319.     CrossRef

Huntington’s disease (HD) is a neurodegenerative disorder characterized by a triad of choreoathetosis, dementia and dominant inheritance. The cause of HD is an expansion of CAG trinucleotide repeats in the HD gene. Typical age at onset of symptoms is in the 40s, but the disorder can manifest at any time. Late-onset (≥ 60 years) HD is clinically different from other adult or juvenile onset HD and characterized by mild motor problem as the initial symptoms, shorter disease duration, frequent lack of family history, and relatively low CAG repeats expansion. We report a case of an 80-year-old female with oromandibular dyskinesia as an initial manifestation of HD and 40 CAG repeats.

Citations

Citations to this article as recorded by  

• The oral manifestations of Huntington's disease: A systematic review of prevalence
  Luciana Munhoz, Ashjan Qasim Jabbar, William José e Silva Filho, Aline Yukari Nagai, Emiko Saito Arita
  Oral Diseases.2023; 29(1): 62.     CrossRef
• Orofacial Dyskinesia and Intractable Hiccups in a Patient with Varicella-zoster Virus Encephalomyelitis
  Akito Funatsu, Yohei Yamamoto, Midori Araki, Fumitoshi Aga, Hideki Mine
  Internal Medicine.2023; 62(1): 119.     CrossRef
• Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK
  Mohamed Z. Habib, Mariane G. Tadros, Hadwa A. Abd-Alkhalek, Magda I. Mohamad, Dalia M. Eid, Fatma E. Hassan, Hend Elhelaly, Yasser el Faramawy, Sawsan Aboul-Fotouh
  European Journal of Pharmacology.2022; 927: 175046.     CrossRef
• Management of Traumatic Ulcerations of Lips in a Case of Huntington’s Disease: A Novel Application of Essix Retainer
  Mohamed Iqbal J
  Journal of Indian Orthodontic Society.2021; 55(4): 415.     CrossRef

Pisa syndrome is (PS) usually seen in patients receiving antipsychotic drugs and characterised by lateral flexion of trunk and axial dystonia. It is believed that antipsychotic drugs lead to dopamine blockage causing PS. We describe a Parkinson’s disease patient who was doing well with levodopa/carbidopa for 3 years and developed lateral flexion of trunk. His abnormal posture used to completely improve upon lying down position. He also had striatal hand deformity suggestive of focal dystonia.

Citations

Citations to this article as recorded by  

• Pisa syndrome in dementia with Lewy bodies: A Chinese multicenter study
  Zhou Su, Shuai Liu, Gang Chen, Jinghuan Gan, Xinran Bao, Hongcan Zhu, Xiaodan Wang, Hao Wu, Yong Ji
  Parkinsonism & Related Disorders.2022; 103: 50.     CrossRef
• Pisa syndrome due to shunt malfunction in normal pressure hydrocephalus with comorbid Parkinson’s disease
  Halil Onder
  Annals of Movement Disorders.2022; 5(1): 68.     CrossRef
• Striatal hand in an elderly man with disseminated tuberculosis: An unusual first case
  Rohit Gaude, Upinder Kaur, Ishan Kumar, Deepak K Gautam, Indrajeet S Gambhir, Sankha S Chakrabarti
  Geriatrics & Gerontology International.2018; 18(8): 1300.     CrossRef
• Frequency and clinical correlates of postural and striatal deformities in Parkinson’s disease
  Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Hugo Morales-Briceño, Gabriel Neri-Nani, Roxanna Millán-Cepeda, Salvador Velázquez-Osuna
  Clinical Neurology and Neurosurgery.2016; 142: 140.     CrossRef
• Pisa syndrome in Parkinson's disease: An integrated approach from pathophysiology to management
  Michele Tinazzi, Christian Geroin, Marialuisa Gandolfi, Nicola Smania, Stefano Tamburin, Francesca Morgante, Alfonso Fasano
  Movement Disorders.2016; 31(12): 1785.     CrossRef
• Reversible Parkinsonism and Pisa Syndrome in Juvenile Normal Pressure Hydrocephalus
  Sanjay Pandey
  Movement Disorders Clinical Practice.2015; 2(1): 72.     CrossRef

Hoarseness and dysphonia are often a result of vocal cord polyps which in turn, are linked to vocal trauma. We report the case of vocal polyps in the setting of a 27-year old male with a history only remarkable for Tourette syndrome. We review the literature regarding etiology and pathophysiology of vocal cord lesions and propose vocal tics in Tourette syndrome as an under-recognized etiology. In this way, we also review therapies that may aid in treating not only the vocal cord lesions but also particularly in the setting of vocal tics.

Citations

Citations to this article as recorded by  

• DISTRIBUTION OF BENIGN LARYNGEAL TUMORS IN CORRELATION WITH DURATION OF CIGARETTE SMOKING
  Slaviša Radosavljević, Miško Živić, Marija Conić-Miletić, Biljana Kostić-Inić
  Acta Medica Medianae.2017; 56(2): 13.     CrossRef

Slow orthostatic tremor (OT) occurred to longer and lower frequency regular rhythmic bursts in leg muscle upon standing. The slow OT was often able to clinically confused with orthostatic myoclonus. We described a Parkinson’s disease patient with levodopa responsive slow OT. She showed abnormal movements of more regular rhythms and stable frequency on both legs on standing. These symptoms were aggravated at off state and improved by increasing levodopa.

Citations

Citations to this article as recorded by  

• Three hertz orthostatic tremor as "red flag sign" candidate for multiple system atrophy
  Yuzhou Wang, Churong Liu, Wenhua Zheng, Mengyun Li, Xiaodi Li
  Neurological Sciences.2024;[Epub]     CrossRef
• Orthostatic myoclonus – A retrospective study of Asian patients
  Yi-Cheng Tai, Hung-Chang Kuo, Yihui Wu, Shih-Pin Hsu
  Journal of the Formosan Medical Association.2022; 121(7): 1310.     CrossRef
• Therapeutic Devices for Motor Symptoms in Parkinson’s Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials
  Joji Fujikawa, Ryoma Morigaki, Nobuaki Yamamoto, Teruo Oda, Hiroshi Nakanishi, Yuishin Izumi, Yasushi Takagi
  Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
• Unilateral Pseudo-Orthostatic Tremor Provoked by a Remote Limb Movement in Parkinson’s Disease
  Sang-Won Yoo, Youngje Heo, Joong-Seok Kim, Kwang-Soo Lee
  Journal of Movement Disorders.2020; 13(1): 69.     CrossRef
• Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
  Fumihito Yoshii, Wakoh Takahashi, Koji Aono
  Case Reports in Neurology.2020; 12(1): 1.     CrossRef